indoleacetic acid has been researched along with Centriacinar Emphysema in 1 studies
indoleacetic acid: RN given refers to unlabeled parent cpd; structure in Merck Index, 9th ed, #4841
auxin : Any of a group of compounds, both naturally occurring and synthetic, that induce cell elongation in plant stems (from Greek alphaupsilonxialphanuomega, "to grow").
indole-3-acetic acid : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens has been replaced by a 1H-indol-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Segal, LN | 1 |
| Clemente, JC | 1 |
| Wu, BG | 1 |
| Wikoff, WR | 1 |
| Gao, Z | 1 |
| Li, Y | 1 |
| Ko, JP | 1 |
| Rom, WN | 1 |
| Blaser, MJ | 1 |
| Weiden, MD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Chronic Obstructive Pulmonary Disease Transcription Factor and Cytokine Study[NCT02557958] | Early Phase 1 | 19 participants (Actual) | Interventional | 2009-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for indoleacetic acid and Centriacinar Emphysema
| Article | Year |
|---|---|
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Bronchoalveolar Lavage Fluid; Chemokine CXCL1; Cytokines; | 2017 |